Pharmacology News and Research

Latest Pharmacology News and Research

Evotec AG announces Closing conditions to acquire DeveloGen

Evotec AG today announced the Closing of the agreement to acquire DeveloGen as announced in detail on 14 July 2010.

2 Sep 2010

Latest achievements in brain research and treatment for mental disorders

Mental disorders, such as depression, anxiety disorders, addiction and schizophrenia are the core challenge of most health care systems around the world. In the EU alone, each year 27% of the total adult population - this corresponds to 83 Million citizens - suffer from mental disorders. Depression alone affects almost 20 million ranking in the EU as the most disabling disorder of all diseases.

30 Aug 2010

23rd ECNP Congress press conference

The incidence of psychotic disorders varies greatly across places and demographic groups, as do symptoms, course, and treatment response across individuals. High rates of schizophrenia in large cities, and among immigrants, cannabis users, and traumatised individuals reflect the causal influence of environmental exposures. This, in combination with progress in the area of molecular genetics, has generated interest in more complicated models of schizophrenia aetiology that explicitly posit gene-environment interactions.

30 Aug 2010

Scientists develop new combined treatment method for skin cancer prevention

Scientists at The University of Texas Health Science Center San Antonio are on to something that should bring joy to sunbathers everywhere. Studies show that certain plant substances, administered in combinations, have the ability to suppress skin cancer development in susceptible mice.

30 Aug 2010

Recent releases in Global Health

"[N]ew diagnostic techniques [for tuberculosis] need to be studied in children," according to a Lancet Infectious Diseases Reflection. "Tuberculosis is an important cause of morbidity and mortality in children worldwide, but estimates of disease burden are inaccurate because most cases are not confirmed," the author writes. He discusses a study published in the same issue that examines various methods for diagnosing TB in children.

27 Aug 2010

Expansion of rapid response systems throughout the Veterans Affairs network can reduce morbidity

Implementing a rapid response team to aid in managing "potentially unstable" patients has led to a sharp reduction in the rate of cardiac arrests at a U.S. Veterans Affairs (VA) hospital, reports a study in the September issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

27 Aug 2010

'Neural inertia' may explain brain's resistance to changes in consciousness

Despite the fact that an estimated 25 million patients per year in the U.S. undergo surgeries using general anesthesia, scientists have only been able to hypothesize exactly how anesthetics interact with the central nervous system. They previously thought that the processes of "going under" and waking up from anesthesia affected the brain in the same way.

27 Aug 2010

Disulfiram drug effective in treating cocaine addiction: Research

Doctors have used the drug disulfiram to help patients stay sober for several decades. It interferes with the body's ability to metabolize alcohol, giving a fierce hangover to someone who consumes even a small amount of alcohol.More recently, disulfiram was shown to be effective in treating cocaine addiction as well, even though alcohol and cocaine affect the nervous system in different ways.

27 Aug 2010

Surgical robots could be used for teleanesthesia: Study

An existing surgical robot could be used to perform complex regional anesthesia procedures—in theory, allowing expert anesthesiologists to perform robot-assisted procedures from remote locations, according to a study in the September issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

27 Aug 2010

23rd European College of Neuropsychopharmacology Congress to be held 28 Aug - 1 Sep 2010 in Amsterdam

26 Aug 2010

FDA approves Chelsea Therapeutics' Phase II protocol for CH-4051 antifolate in rheumatoid arthritis

Chelsea Therapeutics International, Ltd. announced confirmation by the U.S. Food and Drug Administration (FDA) that its proposed Phase II protocol for CH-4051 in rheumatoid arthritis has been approved by the agency.

26 Aug 2010

Scientists create novel map of lipid locations in single cell

In real estate, location is everything. The same might be said of lipids - those crucial cellular fats and oils that serve as building blocks for cells and as key energy sources for the body.In a paper published in the September issue of the Journal of Lipid Research, a team of scientists, led by researchers at the University of California, San Diego School of Medicine, has mapped for the first time the actual locations of specific lipids within a single cell.

26 Aug 2010

Continuous boosting of natural painkiller shuts down brain cell receptor response

ERepeatedly boosting brain levels of one natural painkiller soon shuts down the brain cell receptors that respond to it, so that the painkilling effect is lost, according to a surprising new study led by Scripps Research Institute and Virginia Commonwealth University scientists. The study has important implications for drug development.

25 Aug 2010

Researchers identify novel approach to decrease glioblastoma multiforme recurrence

Researchers from the University of Massachusetts Medical School have identified a novel approach of combining chemotherapy with a targeted therapy to decrease the recurrence of glioblastoma multiforme, the most common and aggressive brain tumor.

25 Aug 2010

Assured Pharmacy reports 20.8% increase in same store sales

OTC Stock Review announces that it has initiated coverage of Assured Pharmacy, Inc. Assured Pharmacy, a growing chain of specialty pharmacies specializing in servicing patients who live with chronic pain, just reported a 20.8 percent increase in same store sales for June 2010 versus June 2009.

24 Aug 2010

Gold Standard/Elsevier launches consumer medication information in 12 foreign languages

Gold Standard/Elsevier, a leading developer of drug information and medication management solutions, announced today the launch of MEDcounselor Languages, a module that provides trusted MEDcounselor consumer medication information in 12 foreign languages. The new MEDcounselor Languages will enable healthcare providers to help non-English speaking patients better understand their drug therapy, take their medications safely, and avoid potentially harmful errors.

24 Aug 2010

Spaulding Clinical becomes world’s largest provider for Mortara Surveyor telemetry-monitoring capability

Spaulding Clinical Research, a Phase 1 Clinical Pharmacology Research Unit and Core ECG Lab announced today that renovation of the clinic's second floor, which was completed on Aug. 20, has made Spaulding Clinical the largest provider of Mortara Surveyor telemetry-monitoring capability in the clinical research world.

24 Aug 2010

Pharma-Nutrition conference to highlight latest research on medical nutrition

Pharma-Nutrition, the new international scientific conference organised by Elsevier, the leading publisher of scientific, technical and medical information products and services, aims to discuss the latest research, concepts and practical applications of medical nutrition in patient treatments, disease management and patient outcomes.

21 Aug 2010

Study finds ketamine restores connection in chronic stress affected brain cells

Yale researchers have discovered how a novel anti-depressant can take effect in hours, rather than the weeks or months usually required for most drugs currently on the market.

20 Aug 2010

Renin test can predict appropriate drugs for BP patients: Study

Commonly prescribed drugs used to lower blood pressure can actually have the opposite effect-raising blood pressure in a statistically significant percentage of patients. A new study by researchers at Albert Einstein College of Medicine of Yeshiva University suggests that doctors could avoid this problem-and select drugs most suitable for their patients-by measuring blood levels of the enzyme renin through a blood test that is becoming more widely available. The study appears in the online edition of the American Journal of Hypertension.

20 Aug 2010